Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2006
03/16/2006US20060058515 Disazo reactive dyestuffs containing the quaternary groups and their use
03/16/2006US20060058395 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy
03/16/2006US20060058366 Jnk inhibitor
03/16/2006US20060058362 7-Amido-isoindolyl compounds and methods of their use
03/16/2006US20060058357 Delta2-1,2,3-triazoline anticonvulsants and their active metabolite analogues, the aminoalkylpyridines, are excitatory amino acid antagonists and antiischemic agents, useful in the treatment of cerebral ischemia resulting from stroke
03/16/2006US20060058356 Indolylmaleimide derivatives
03/16/2006US20060058351 Novel ligands that modulate LXR-type receptors and cosmetic/pharmaceutical applications thereof
03/16/2006US20060058349 Piperidinetriol derivatives as inhibitors of glycosyceramid synthase
03/16/2006US20060058346 Novel enantiomers of etrahydroisoquinoline derivatives and theirpharmaceutically acceptable salts, their preparations and pharmaceutical compositions
03/16/2006US20060058334 provides substantially pure desloratadine having an HPLC purity greater than 99.5% and having an absorbance less than 0.15 Au at 420 nm for a 5% w/v solution in methanol; acidic hydrolysis; 8-chloro-6,11-dihydro-11-(4-piperidinylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine; allergic rhinitis
03/16/2006US20060058329 Pyrazole inhibitors of the transforming growth factor
03/16/2006US20060058315 2-Oxo-ethanesulfonamide derivates
03/16/2006US20060058309 Respiratory syncytial virus replication inhibitors
03/16/2006US20060058298 Inhibitors of histone deacetylase
03/16/2006US20060058292 2,4-pyrimidinediamine compounds and their uses
03/16/2006US20060058285 Substituted 4-(4-piperidin-4-yl-piperazin-1-yl)-azepane derivatives and their use as neurokinin antagonists
03/16/2006US20060058178 Aromatic compounds containing nitrogen and p- functionalized amines, the production thereof and their use in catalytic reactions
03/16/2006DE102004043826A1 Mixture of two metal azo complexes useful as a light absorber in the information layer of a write-once optical data carrier
03/16/2006CA2591321A1 Phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase
03/16/2006CA2579886A1 Novel imidazolidine derivative and use thereof
03/16/2006CA2578996A1 4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms
03/16/2006CA2578739A1 Quinazolines useful as modulators of ion channels
03/15/2006EP1634926A1 Selected cationic diazo compounds, compositions comprising them as direct dye, methods for dyeing keratin fibres and kit
03/15/2006EP1634879A1 Method of selectively introducing amino substituent
03/15/2006EP1634873A1 Sigma receptor inhibitors
03/15/2006EP1633746A1 New indole derivatives as factor xa inhibitors
03/15/2006EP1633743A1 Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin
03/15/2006EP1633740A2 Chemical compounds
03/15/2006EP1633738A2 Novel indole derivatives, method of preparing same in the form of medicaments, pharmaceutical compositions and, in particular, kdr inhibitors
03/15/2006EP1633737A1 Quinolyl amide derivatives as ccr-5 antagonists
03/15/2006EP1633736A1 Barium salt of benzimidazole derivative
03/15/2006EP1633735A1 Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
03/15/2006EP1633734A2 Mucin synthesis inhibitors
03/15/2006EP1633732A1 Benzyl sulfonamide derivatives as androgen receptor antagonists
03/15/2006EP1633729A1 Sulphonamide compounds that modulate chemokine receptor activity (ccr4)
03/15/2006EP1633726A1 Pyrimidine derivatives useful for the treatment of diseases mediated by crth2
03/15/2006EP1633725A1 Hepatitis c virus inhibitors
03/15/2006EP1633724A1 Phthalazinone derivatives
03/15/2006EP1633723A1 Sulphonamide compounds that modulate chemokine receptor activity (ccr4)
03/15/2006EP1633717A1 New p2x7 receptor antagonists and their use
03/15/2006EP1633715A1 2-(6-amino-pyridin-3-yl)-2-hydroxyethylamine derivatives as beta 2-adrenoceptors agonists
03/15/2006EP1633712A2 Six membered amino-amide derivatives as angiogenesis inhibitors
03/15/2006EP1633710A1 Isoindolin-1-one compounds as kinase inhibitors
03/15/2006EP1633709A1 Anti-diabetic agents
03/15/2006EP1633702A1 Protease inhibitors
03/15/2006EP1633694A2 Substituted indoles and a process for preparing substituted indoles
03/15/2006EP1633363A1 Pyridinyl acetonitriles
03/15/2006EP1633349A1 4-bromo-5- (2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl) eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
03/15/2006EP1633348A1 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B sb 1 /sb RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES
03/15/2006EP1633346A1 Pyrrolidin-1, 2- dicarboxylic acid- 1- (4- ethinyl- phenyl) - amid]- 2- (phenyl)- amid] derivative as inhibitors of coagulation factor xa and viia for the treatment of thrombosis
03/15/2006EP1567151B1 3-(2-hydroxy-phenyl)-1h-pyrazole-4-carboxylic acid amide derivatives as hsp90 inhibitors for the treatment of cancer
03/15/2006EP1465864B1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
03/15/2006EP1448566B1 Chemokine receptor antagonists and methods of use thereof
03/15/2006EP1403249B1 Cyclic diamine compounds bearing six-membered cyclic groups
03/15/2006EP1326864B1 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
03/15/2006EP1309593B1 Substituted pyrazoles
03/15/2006EP1020446B1 Naphthalimidobenzamide derivatives
03/15/2006CN1747951A Novel 2-pyridinecarboxamide derivatives
03/15/2006CN1747950A 2-(1h-indazole-6-ylamino)-benzamide compounds as protein kinases inhibitors useful for the treatment of ophthalmic diseases
03/15/2006CN1747949A Acyclic pyrazole compounds
03/15/2006CN1747939A Amino 1, 3, 5-triazines n-substituted with chiral bicyclic radicals, process for their preparation, compositions thereof and their use as herbicides and plant growth regulators
03/15/2006CN1747936A Substituted azole derivatives as therapeutic agents
03/15/2006CN1747929A Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor
03/15/2006CN1747730A Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity
03/15/2006CN1746166A Hexahydro-phthalmide compound, its preparation and use thereof
03/15/2006CN1245402C Indole derivatives, their preparation, medicinal compositions containing them and use thereof
03/15/2006CN1245401C 6-aryl-4-aminopicolinates and their use as herbicides
03/15/2006CN1245391C Pyrimidine, Triazine and pyrazine derivatives as glutamate receptors
03/15/2006CN1245386C 1,2-dihydropyridine compounds, process for preparation of same and use thereof
03/15/2006CN1245385C Indole and dihydroindole derivatives
03/15/2006CN1245155C Oral pharmaceutical pulsed release dosage form
03/14/2006US7012144 Bactericides
03/14/2006US7012094 such as 3-(4-fluorophenyl)-4-(methylsulfonylphenyl)furan; for treatment of arthritis
03/14/2006US7012085 As antipsychotics in therapy of schizophrenia, depression, bipolar disorders, cognition deficits, Parkinson disease, drug abuse, attention deficit hyperactivity disorders, glaucoma, diabetes and erectile dysfunction
03/14/2006US7012081 Antiproliferative agents; skin disorders; vision defects; liver and kidney disorders
03/14/2006US7012078 For therapy and prophylaxis of migraine, inflammatory diseases, stroke, acute and chronic pain, hypovolemic shock, traumatic shock, reperfusion injury, Crohn's disease, ulcerative colitis, septic shock, multiple sclerosis, etc.
03/14/2006US7012077 Anticholesterol agents; antilipemic agents
03/14/2006US7012075 Cathepsin cysteine protease inhibitors
03/14/2006US7012073 Quinoline derivatives
03/14/2006US7011875 Optical information-recording medium and dye
03/14/2006CA2359363C 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
03/14/2006CA2312935C Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors
03/14/2006CA2308867C New substitute pyridine or piperidine compounds, their preparation process and the pharmaceutical compositions containing these compounds
03/14/2006CA2289987C Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
03/14/2006CA2267879C Heteroaryl succinamides and their use as metalloproteinase inhibitors
03/14/2006CA2239547C Benzazepine derivatives with vasopressin agonistic activity
03/14/2006CA2237005C Quinazoline derivatives
03/14/2006CA2176557C Phenyl-alkyl imidazoles as h3-receptor antagonists
03/14/2006CA2165800C Antiallergic imidazoazepines
03/14/2006CA2103838C Novel 7-(substituted)-8-(substituted-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
03/14/2006CA1341498C Polysubstituted aryl acridinium esters
03/09/2006WO2006026703A2 Chemical compounds
03/09/2006WO2006025979A2 Modulators of nuclear receptors
03/09/2006WO2006025480A1 7-substituted carbostyril derivative and method for producing same
03/09/2006WO2006025479A1 Method for producing n-(1-methylbenzoimidazole-2-yl)methyl-n'-2- [(carbostyryl-7-yl)oxy]ethylhomopiperazine
03/09/2006WO2006025471A1 Piperidine derivative or pharmaceutically acceptable salt thereof
03/09/2006WO2006024863A1 Stable crystal form of imatinib mesylate and process for the preparation thereof
03/09/2006WO2006024837A1 Isoindolin-1-one derivatives
03/09/2006WO2006024823A1 Pyrimidine sulphonamide derivatives as chemokine receptor modulators
03/09/2006WO2006024777A1 Pyrrole derivatives, their preparation and their therapeutic use